# Modified-FLAI Induction and Consolidation Chemotherapy in Elderly Patient With Acute Myeloid Leukemia (AML)

> **NCT01247493** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 108 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** induction chemotherapy (fludarabine, cytarabine, idarubicin)

## Key facts

- **NCT ID:** NCT01247493
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-06
- **Final completion:** 2010-07
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2010-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01247493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01247493, "Modified-FLAI Induction and Consolidation Chemotherapy in Elderly Patient With Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01247493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*